Concepedia

Author

Niall C. Tebbutt

Austin HealthORCID

Also Known As

K. M. Sjoquist, Michael Michael, N C Tebbutt, N Tebbutt, N. C. Tebbutt, N. Tebbutt, N.C Tebbutt, N.C. Tebbutt, Niall C TEBBUTT, Niall C Tebbutt

509

Publications

23.9K

Citations

65

H-Index

90

Concepts

All Affiliations

Austin HealthThe University of MelbourneThe University of SydneyPeter MacCallum Cancer CentreQueen Elizabeth Hospital
NC

About

Niall C. Tebbutt is an author at Austin Health specializing in medicine, oncology, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

37

80

8.5K

2

Health Sciences

16

22

1.2K

3

Natural Sciences

2

2

88

4

Public Health

1

1

46

5

Biochemistry

1

1

54

Niall C. Tebbutt

×

155

Publications

21.9K

Citations

63

H-Index

YearCitations

<i>K-ras</i> Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer

Christos S. Karapetis, Shirin Khambata‐Ford, Derek J. Jonker,

New England Journal of Medicine

2008

3.6K

Cetuximab for the Treatment of Colorectal Cancer

Derek J. Jonker, Chris J. O’Callaghan, Christos S. Karapetis,

New England Journal of Medicine

2007

1.8K

Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial

Kohei Shitara, Mustafa Özgüroğlu, Yung‐Jue Bang,

The Lancet

2018

1.3K

Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial

Andrea Wang‐Gillam, Chung‐Pin Li, G. Bodoky,

The Lancet

2015

1.2K

Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database

Jan Franko, Qian Shi, Jeffrey P. Meyers,

The Lancet Oncology

2016

628

Effect of Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid or Gemcitabine vs Observation on Survival in Patients With Resected Periampullary Adenocarcinoma

John P. Neoptolemos, Malcolm J. Moore, Trevor F. Cox,

JAMA

2012

574

Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial

Cathy Eng, Tae Won Kim, Johanna C. Bendell,

The Lancet Oncology

2019

543

Everolimus for Previously Treated Advanced Gastric Cancer: Results of the Randomized, Double-Blind, Phase III GRANITE-1 Study

Atsushi Ohtsu, Jaffer A. Ajani, Yu-Xian Bai,

Journal of Clinical Oncology

2013

487

Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Biomarker Evaluation From the AVAGAST Randomized Phase III Trial

Eric Van Cutsem, Sanne de Haas, Yoon‐Koo Kang,

Journal of Clinical Oncology

2012

482

Neoadjuvant Capecitabine and Oxaliplatin Followed by Synchronous Chemoradiation and Total Mesorectal Excision in Magnetic Resonance Imaging–Defined Poor-Risk Rectal Cancer

Ian Chau, Gina Brown, David Cunningham,

Journal of Clinical Oncology

2006

477

Page 1